Jaguar Health Inc (JAGX)

[TJG]

I dont think that will have anything to do with the announcement.... here is why In 2005 Jaguar began the development of Crofelemer for the treatment of diarrhea in HIV patients... they went thru all three Phases of trial and in June of 2012 the completed the Phase III trial with positive results.... the drug was then submitted to the FDA for approval and was subsequently approved by the FDA in December of 2012... they did not submit an abstract for that drug trial at the beginning or the end.

How ever in June of 2021 they submitted an Abstract for the human trial regarding diarrhea for chemotherapy patients and that abstract was accept... the abstract had to do with the beginning of the Phase I or III trials that began in 2020... so here we are 4 years later and the trials are completed. The point is with ASCO you can submit to them anytime you are involved with a Phase I II or III trial to update your progress... they are not restricted against releasing the information before submitting the abstract. For those who are wondering an Abstract is just a paper outlining the process of the drug and what it does and if successful how it benifits a patient... Its a history of the drug up to date. The Abstract they submitted in 2021 regarding the trial that started in 2020 was a recap of where they were and what they were trying to accomplish.

If completed I see no reason why they would wait until to announce it... they can release the positive results with out releasing the completed details... As they did witrh the HIV trial they completed the Phase III trial, analyzed the data and submitted it to the FDA and 5 months later it was approved... they will do the dame thing here... They are not going to hold off submitting to the FDA by weeks just so they can present the Abstract to ASCO... that would then set the FDA approval to early 2025 and there is no way they can afford to wait that long...

Remember that the Feb 23 press release concerning the hearing for under 10 cent minimum bid price had this paragraph in it.... It basically is saying when have analyzed the results of the Phase III trial we will release it.

https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-requests-and-receives-hearing-nasdaq-listing

"We continue to work diligently to complete the comprehensive analysis of the data from our pivotal Phase 3 OnTarget trial of our novel plant-based prescription drug crofelemer for the follow-on indication of the preventative treatment of cancer therapy-related diarrhea."

The word Complete is Key...if they were not going to release it they would have said We continue to analyze the Phase III data.. but the said To Complete the comprehensive analysis .. Very important